Immunohematology Market Report 2024 (Global Edition)

Global Immunohematology Market Report 2024 Market Size Split by Product (Analyzing Systems, Reagents and Consumables), by Technology (Biochips, Gel Cards, Microplates, Polymerase Chain Reaction, Eryth...

Immunohematology Market Report Description

We have various report editions of Immunohematology Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Immunohematology Market Insights Video

Competitive Landscape of the Immunohematology Market

The competitive landscape of the Immunohematology market is characterized by a diverse range of global and regional players focusing on advanced diagnostic solutions. Key companies, such as Grifols, Immucor, and Ortho Clinical Diagnostics, lead with innovative blood typing and cross-matching technologies. The market is marked by strategic collaborations, mergers, and acquisitions aimed at expanding product portfolios and enhancing market reach. Technological advancements and increasing demand for blood transfusion safety drive competition, while regulatory compliance and product quality remain critical. Emerging players and startups also contribute to the dynamic landscape by offering niche and specialized solutions.

May 2022: A new haematology analyzer reagent factory was created by Nihon Kohden Corporation, an Indian company. (Source: https://www.nihonkohden.com/news/22050601.html) April 2022: The XQ-320 XQ-Series Automated Hematology Analyzer, a new three-part differential system from Sysmex Europe, was introduced. It has several features for patient data security and quality management. (Source: https://www.sysmex-europe.com/products/products-detail/xq-320/)

Top Companies Market Share in Immunohematology Industry: (In no particular order of Rank)

• Siemens Healthcare GmbH
• Abbott Antisel
• Beckman Coulter Inc.(Danaher Corporation)
• MTC Invitro Diagnostics AG
• Ortho-Clinical Diagnostics Inc (The Carlyle Group)
• Merck KGaA
• B.D. (Becton Dickinson and Company)
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Immunohematology Market

Which Region Dominates the Immunohematology Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue through advanced healthcare infrastructure, a high prevalence of blood disorders, and significant investments in research and development. The U.S. and Canada lead in technological innovations and the adoption of sophisticated diagnostic and blood screening technologies.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the Immunohematology market by increasing healthcare investments, rising awareness, and advancements in diagnostic technologies. The region's growing population and expanding healthcare infrastructure further contribute to its significant growth in this market.

The current report Scope analyzes Immunohematology Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Immunohematology Market

According to Cognitive Market Research, the global Immunohematology market size was estimated at USD 2142.6 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 857.04 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031.

• According to Cognitive Market Research, the U.S. had a major share in the Immunohematology market with a market size of USD 676.20 million in 2024 and is projected to grow at a CAGR of 7.7% during the forecast period. The nation's advancements in advanced technology and demand.
• The Canadian immunohematology market had a market share of USD 102.84 million in 2024 and is projected to grow at a CAGR of 8.7% during the forecast period. Canada's strict due to advanced technology and innovation.
• The Mexico Immunohematology market is projected to witness growth at a CAGR of 8.4% during the forecast period, with a market size of USD 77.99 million in 2024.

Europe Immunohematology Market

According to Cognitive Market Research, the global Immunohematology market size was estimated at USD 2142.6 Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD 642.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031.

• The United Kingdom Immunohematology market had a market share of USD 107.99 million in 2024 and is projected to grow at a CAGR of 9.0% during the forecast period. In the U.K., Immunohematology sales witness an upswing with innovation and strong healthcare.
• The France Immunohematology market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD XX million in 2024.
• According to Cognitive Market Research, the German Immunohematology market size was valued at USD 127.27 million in 2024 and is projected to grow at a CAGR of 7.4% during the forecast period. In Germany, Immunohematology surged due to advanced technology and research.
• The Italy Immunohematology market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 55.28 million in 2024.
• The Russian immunohematology market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 99.63 million in 2024.
• The Spain Immunohematology market is projected to witness growth at a CAGR of 7.3% during the forecast period with a market size of USD 52.71 million in 2024
• The Luxembourg Immunohematology market is projected to witness growth at a CAGR of 8.3% during the forecast period, with a market size of USD 19.93 million in 2024.
• The Portugal Immunohematology market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 13.50 million in 2024.
• The Greece Immunohematology market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 7.71 million in 2024.
• Rest of Europe's Immunohematology market is projected to witness growth at a CAGR of 6.9% during the forecast period, with a market size of USD 99.63 million in 2024.

Asia Pacific Immunohematology Market

According to Cognitive Market Research, the global Immunohematology market size was estimated at USD 2142.6 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 492.80 million in 2024 and will grow at a compound annual growth (CAGR) of 11.7% from 2024 to 2031.

• According to Cognitive Market Research, the China Immunohematology market size was valued at USD 221.76 million in 2024 and is projected to grow at a CAGR of 11.2% during the forecast period. Immunohematology surged in China stems of advanced technology and its large population.
• The Japan Immunohematology market is projected to witness growth at a CAGR of 10.2% during the forecast period, with a market size of USD 68.01 million in 2024.
• The India Immunohematology market had a market share of USD 59.14 million in 2024 and is projected to grow at a CAGR of 13.5% during the forecast period. India is supportive of innovation, increasing healthcare needs.
• The South Korean Immunohematology market is projected to witness growth at a CAGR of 10.8% during the forecast period, with a market size of USD 49.28 million in 2024.
• The Australian Immunohematology market is projected to witness growth at a CAGR of 11.4% during the forecast period, with a market size of USD 25.63 million in 2024.
• The Southeast Asia Immunohematology market is projected to witness growth at a CAGR of 12.7% during the forecast period, with a market size of USD 34.00 million in 2024.
• The Rest of Asia Pacific Immunohematology market is projected to witness growth at a CAGR of 11.5% during the forecast period, with a market size of USD 34.99 million in 2024.

South America Immunohematology Market

According to Cognitive Market Research, the global Immunohematology market size was estimated at USD 2142.6 Million, out of which the Latin America market has more than 5% of the global revenue with a market size of USD 107.13 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.1% from 2024 to 2031. .

• According to Cognitive Market Research, the Brazil Immunohematology market size was valued at USD 45.85 million in 2024 and is projected to grow at a CAGR of 9.7% during the forecast period. Immunohematology flourished in Brazil with advanced healthcare infrastructure and innovation.
• Argentina's Immunohematology market had a market share of USD 18.00 million in 2024 and is projected to grow at a CAGR of 10.0% during the forecast period. Argentina's due to strong healthcare infrastructureli>
• Colombia's Immunohematology market is projected to witness growth at a CAGR of 8.9% during the forecast period, with a market size of USD 9.53 million in 2024.
• Peru Immunohematology market is projected to witness growth at a CAGR of 9.3% during the forecast period, with a market size of USD 8.78 million in 2024.
• Chile's Immunohematology market is projected to witness growth at a CAGR of 9.4% during the forecast period, with a market size of USD 7.71 million in 2024.
• The Rest of Latin America's Immunohematology market is projected to witness growth at a CAGR of 8.2% during the forecast period, with a market size of USD 17.25 million in 2024.

Middle East and Africa Immunohematology Market

According to Cognitive Market Research, the global Immunohematology market size was estimated at USD 2142.6 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 42.85million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.4% from 2024 to 2031..

• The GCC Countries Immunohematology market is projected to witness growth at a CAGR of 10.2% during the forecast period, with a market size of USD 18.34 million in 2024. Immunohematology sales flourish due to advanced healthcare infrastructure.
• The Egypt Immunohematology market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD 4.50 million in 2024.
• The South African immunohematology market is projected to witness growth at a CAGR of 10.4% during the forecast period, with a market size of USD 6.77 million in 2024. Immunohematology sales flourish in South Africa with advanced technologies and infrastructure.
• The Turkey Immunohematology market is projected to witness growth at a CAGR of 8.9% during the forecast period, with a market size of USD 3.69 million in 2024.
• The Nigeria Immunohematology market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 4.50 million in 2024.
• The Rest of the MEA Immunohematology market is projected to witness growth at a CAGR of 8.4% during the forecast period, with a market size of USD 5.06 million in 2024.

Immunohematology Market Analysis

Immunohematology Market Product Segment Analysis

According to Cognitive Market Research, Reagents and Consumables stand out as the dominant category due to their essential role in blood typing, crossmatching, and antibody screening. These products are crucial for ensuring accurate and efficient blood transfusions and diagnostics. Their continuous innovation, such as the development of advanced reagents with higher sensitivity and specificity, drives demand. Additionally, the increasing prevalence of blood disorders and a growing emphasis on safety and precision in transfusion medicine contribute to the rising need for high-quality reagents and consumables. As healthcare systems prioritize improved blood management and patient care, the market for these products expands rapidly.

Analyzing Systems emerges as the fastest-growing category in the Immunohematology market. Analyzing Systems by leveraging advanced technologies to enhance accuracy, efficiency, and speed in blood testing and analysis. These systems integrate sophisticated software and automation to streamline workflows, reduce human error, and provide real-time results. Their ability to handle complex data and adapt to emerging requirements in blood transfusion and disease management drives their adoption. Additionally, their role in personalized medicine and regulatory compliance further accelerates their market growth. As healthcare demands evolve, analyzing systems continues to set new standards, making them pivotal in the market's expansion.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Immunohematology Industry. Request a Free Sample PDF!

Immunohematology Market Technology Segment Analysis

According to Cognitive Market Research, the dominant category is Erythrocyte-Magnetized Technology (EMT), with its advanced capabilities. By utilizing magnetic fields to manipulate erythrocytes, EMT enhances blood typing, crossmatching, and antibody screening, leading to more precise and rapid results. This innovation minimizes human error and increases the efficiency of blood transfusions and compatibility testing. As a result, EMT is driving significant growth in the immunohematology sector, attracting investment and attention due to its potential to improve patient outcomes and streamline laboratory processes. Its ability to provide faster, more accurate diagnostics makes it a key player in the market’s expansion.

The fastest-growing category in the Immunohematology market is Microplates due to their versatility, efficiency, and cost-effectiveness in diagnostic testing. They enable high-throughput screening and precise quantification of blood components, which accelerates diagnostic processes and improves accuracy. Their ability to handle multiple samples simultaneously while reducing reagent consumption makes them ideal for large-scale testing. Additionally, advancements in microplate technology, including automation and integration with digital systems, enhance data reliability and streamline workflows. This combination of factors positions microplates as a crucial tool driving innovation and growth in immunohematology diagnostics.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Immunohematology Application Segment Analysis

Immunohematology Market Application Segment Analysis

According to Cognitive Market Research, the dominant category is Blood-Related Diseases due to their complex nature and increasing prevalence. The need for advanced diagnostic tools, blood typing, crossmatching, and immunohematology testing to manage these conditions fuels market expansion. Innovations in treatment and personalized medicine, alongside a rising demand for precise and efficient blood testing solutions, further boosts market growth. Additionally, the growing awareness and advancements in healthcare technology contribute to the expansion, making immunohematology crucial for addressing and managing these critical blood disorders.

The fastest-growing category in the Immunohematology market is Blood Transfusion due to increasing demand for safe, efficient blood products and advancements in transfusion technologies. Enhanced blood compatibility testing, the development of novel blood screening methods, and rising incidences of chronic diseases that require regular transfusions contribute to this trend. Additionally, the growing emphasis on patient safety and personalized medicine fosters innovations in immunohematology. The integration of automation and advanced diagnostic tools further accelerates market expansion as healthcare systems worldwide prioritize improving transfusion practices and ensuring the highest standards of blood safety and efficacy.

• Blood-Related Diseases
• HIV
• Hepatitis
• Blood Transfusion

Immunohematology End_User Segment Analysis

Immunohematology Market End-User Segment Analysis

According to Cognitive Market Research, the dominant category is Hospitals due to their extensive patient care needs and the increasing complexity of blood transfusion services. They require advanced immunohematology products for accurate blood typing, crossmatching, and screening to ensure patient safety and effective treatment. As hospitals expand and upgrade their diagnostic and transfusion capabilities, the demand for innovative immunohematology solutions rises. Additionally, hospitals are key players in adopting cutting-edge technologies and high-quality reagents, further propelling market growth. Their substantial volume of blood-related procedures underscores their central role in the sector's expansion.

The fastest-growing category in the Immunohematology market is Blood Banks due to their pivotal role in blood collection, processing, and transfusion services. Their extensive networks and high demand for safe blood products drive innovation in immunohematology, enhancing blood typing, crossmatching, and disease screening technologies. Advances in these areas improve patient outcomes and streamline operations, fostering market growth. Additionally, blood banks' focus on integrating cutting-edge technologies, like automation and molecular diagnostics, boosts efficiency and accuracy, positioning them at the forefront of the market's expansion. Their strategic importance and technological adoption are key to their dominant market presence.

• Hospitals
• Blood Banks
• Diagnostic Laboratories

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion